Search results for "Sclerosis"

showing 10 items of 1583 documents

Effect of High-Frequency Oscillations on Cough Peak Flows Generated by Mechanical In-Exsufflation in Medically Stable Subjects With Amyotrophic Later…

2016

BACKGROUND: Mechanically assisted coughing with mechanical in-exsufflation (MI-E) is recommended for noninvasive management of respiratory secretions in amyotrophic lateral sclerosis (ALS). To improve the effectiveness of the technique, a new device combining MI-E with high-frequency oscillations (HFO) has been developed. This work aimed to assess the effect of HFO on the cough peak flow generated by MI-E in medically stable subjects with ALS. METHODS: This was a prospective study that included subjects with ALS in a medically stable condition. Cough peak flow generated by MI-E was measured in 4 situations: without HFO, with HFO during insufflation, with HFO during exsufflation, and with HF…

Pulmonary and Respiratory MedicineInsufflationMalemedicine.medical_treatmentHigh-Frequency VentilationPeak Expiratory Flow RateCritical Care and Intensive Care Medicine03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineMedicineHumansNew deviceProspective StudiesRespiratory systemAmyotrophic lateral sclerosisAgedbusiness.industryHigh-frequency ventilationAmyotrophic Lateral SclerosisInsufflationGeneral MedicineMiddle Agedmedicine.diseaseTreatment Outcome030228 respiratory systemRespiratory failureCoughAnesthesiaFemaleExsufflationbusiness030217 neurology & neurosurgeryRespiratory care
researchProduct

Efficacy of Mechanical Insufflation-Exsufflation in Medically Stable Patients With Amyotrophic Lateral Sclerosis

2004

Objective: To determine under what circumstances the use of mechanical insufflation-exsufflation (MI-E) can generate clinically effective expiratory flows for airway clearance (> 2.7 L/s) for clinically stable patients with amyotrophic lateral sclerosis (ALS). Materials and method: Twenty-six consecutive patients with ALS were studied, 15 with severe bulbar dysfunction. Using a pneumotachograph and with the aid of an oronasal mask, we measured FVC, FEV1, peak cough flow (PCF), maximum insufflation capacity (MIC), PCF generated from a maximum insufflation MIC (PCFMIC), and PCF generated by MI-E (PCFMI-E). MI-E was delivered at 40 cm H2O. Maximum inspiratory pressure (PImax) and maximum expir…

Pulmonary and Respiratory MedicineInsufflationNeuromuscular diseasebusiness.industryCritical Care and Intensive Care Medicinemedicine.diseasePulmonary function testingFEV1/FVC ratioAnesthesiamedicineBreathingExsufflationAmyotrophic lateral sclerosisRespiratory systemCardiology and Cardiovascular MedicinebusinessChest
researchProduct

Usefulness of Oscillations Added to Mechanical In-Exsufflation in Amyotrophic Lateral Sclerosis.

2019

BACKGROUND: Assisted coughing via mechanical in-exsufflation (MI-E) is a first-line treatment for secretion management in patients with amyotrophic lateral sclerosis (ALS) with unassisted CPF METHODS: We conducted a 12-month, prospective, randomized follow-up study of subjects with ALS for whom assisted coughing techniques were indicated. One group was treated with oscillations in addition to MI-E (MI-E+O), and the other group was treated with conventional MI-E. RESULTS: 29 subjects were included in the MI-E group and 27 subjects were included in the MI-E+O group. Five subjects (8.9%) required invasive techniques for secretion management (3 in the MI-E group and 2 in the MI-E+O group, P = .…

Pulmonary and Respiratory MedicineMaleCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicineTracheostomyBronchoscopymedicineHumansIn patientProspective StudiesAmyotrophic lateral sclerosisRespiratory systemRespiratory Tract InfectionsAgedAged 80 and overbusiness.industryAmyotrophic Lateral SclerosisInsufflationGeneral MedicineOdds ratioMiddle Agedmedicine.disease030228 respiratory systemCoughAnesthesiaFemaleExsufflationbusinessRespiratory InsufficiencyFollow-Up StudiesRespiratory care
researchProduct

Tolerance of Volume Control Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis.

2015

BACKGROUND: Noninvasive ventilation (NIV) tolerance has been identified as an independent predictor of survival in amyotrophic lateral sclerosis (ALS). Volume control continuous mandatory ventilation (VC-CMV) NIV has been associated with poor tolerance. The aim of this study was to determine the tolerance of subjects with ALS to VC-CMV NIV. METHODS: This was a prospective study involving subjects with ALS who were treated with VC-CMV NIV. Respiratory and functional parameters were recorded when the subjects began ventilatory support. NIV tolerance was evaluated after 3 months. RESULTS: Eighty-seven subjects with ALS were included. After 3 months, 80 subjects (92%) remained tolerant of NIV. …

Pulmonary and Respiratory MedicineMaleNeuromuscular diseaseTime FactorsPeak Expiratory Flow RateCritical Care and Intensive Care MedicineVolume controlContinuous mandatory ventilationForced Expiratory VolumemedicineHumansProspective StudiesRespiratory systemAmyotrophic lateral sclerosisProspective cohort studyAgedNoninvasive Ventilationbusiness.industryAmyotrophic Lateral SclerosisGeneral MedicineMiddle Agedmedicine.diseaseRespiratory failureCoughAnesthesiaNoninvasive ventilationFemalebusinessRespiratory InsufficiencyRespiratory care
researchProduct

Predictors of need for noninvasive ventilation during respiratory tract infections in medically stable, non-ventilated subjects with amyotrophic late…

2014

BACKGROUND: Acute lower respiratory infections can impair muscle strength in patients with amyotrophic lateral sclerosis (ALS). When associated with an increase in load on the respiratory system, this situation may precipitate hypercapnic respiratory failure in non-ventilated patients with ALS. The aim of this study was to determine whether a clinical or functional parameter can predict the need for noninvasive ventilation (NIV) during an acute respiratory infection for medically stable, non-ventilated patients with ALS. METHODS: This was a prospective study involving all non-ventilated subjects with ALS admitted due to an acute respiratory infection to a respiratory care unit from a tertia…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyNeuromuscular diseaseVital CapacityCritical Care and Intensive Care MedicineSeverity of Illness IndexFEV1/FVC ratioPredictive Value of TestsmedicineOdds RatioHumansProspective StudiesAmyotrophic lateral sclerosisRespiratory systemRespiratory Tract InfectionsAgedNoninvasive VentilationRespiratory tract infectionsbusiness.industryAmyotrophic Lateral SclerosisRespiratory infectionInsufflationGeneral MedicineMiddle Agedmedicine.diseaseSurgeryLogistic ModelsRespiratory failureCoughAnesthesiaFemalebusinessRespiratory InsufficiencyRespiratory careRespiratory care
researchProduct

Home Mechanical Ventilation in Amyotrophic Lateral Sclerosis Patients Is Not Always a Problem

2000

Pulmonary and Respiratory MedicineMechanical ventilationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentMasksCritical Care and Intensive Care Medicinemedicine.diseaseHome Care ServicesPositive-Pressure RespirationTracheostomyPhysical medicine and rehabilitationQuality of LifemedicineHumansMotor Neuron DiseaseAmyotrophic lateral sclerosisCardiology and Cardiovascular MedicinebusinessChest
researchProduct

Bulbar impairment score and survival of stable amyotrophic lateral sclerosis patients after noninvasive ventilation initiation

2018

There is general agreement that noninvasive ventilation (NIV) prolongs survival in amyotrophic lateral sclerosis (ALS) and that the main cause of NIV failure is the severity of bulbar dysfunction. However, there is no evidence that bulbar impairment is a contraindication for NIV. The aim of this study was to determine the effect of bulbar impairment on survival in ALS patients with NIV. ALS patients for whom NIV was indicated were included. Those patients who refused NIV were taken as the control group. 120 patients who underwent NIV and 20 who refused NIV were included. The NIV group presented longer survival (median 18.50 months, 95% CI 12.62–24.38 months) than the no-NIV group (3.00 mont…

Pulmonary and Respiratory Medicinebusiness.industrylcsh:Rlcsh:MedicineOriginal Articlesmedicine.disease03 medical and health sciences0302 clinical medicineBulbar dysfunction030228 respiratory system18AnesthesiaMedicineNoninvasive ventilationAmyotrophic lateral sclerosisbusinessContraindication030217 neurology & neurosurgeryERJ Open Research
researchProduct

Unstable control of breathing can lead to ineffective noninvasive ventilation in amyotrophic lateral sclerosis

2019

Upper airway obstruction with decreased central drive (ODCD) is one of the causes of ineffective noninvasive ventilation (NIV) in amyotrophic lateral sclerosis (ALS). The aim of this study is to determine the mechanism responsible for ODCD in ALS patients using NIV. This is a prospective study that included ALS patients with home NIV. Severity of bulbar dysfunction was assessed with the Norris scale bulbar subscore; data on upper or lower bulbar motor neuron predominant dysfunction on physical examination were collected. Polysomnography was performed on every patient while using NIV and the ODCD index (ODCDI: number of ODCD events/total sleep time) was calculated. To determine the possible …

Pulmonary and Respiratory Medicinemedicine.medical_specialty8lcsh:MedicinePolysomnography03 medical and health sciences0302 clinical medicineInternal medicineHyperventilationMedicineAmyotrophic lateral sclerosismedicine.diagnostic_testbusiness.industryUpper motor neuronlcsh:ROriginal Research LetterMotor neuronAirway obstructionmedicine.diseasemedicine.anatomical_structure030228 respiratory systemControl of respirationCardiologymedicine.symptombusinessAirway030217 neurology & neurosurgeryERJ Open Research
researchProduct

Long-term volume-targeted pressure-controlled ventilation: sense or nonsense?

2017

The technology underlying the development of novel ventilatory modes for long-term noninvasive ventilation of patients with chronic hypercapnia is continuously evolving. Volume-targeted pressure-controlled ventilation is a hybrid ventilation mode designed to combine the advantages of conventional ventilation modes, while avoiding their drawbacks. However, manufacturers have created different names and have patented algorithms and set-up variables, which can result in confusion for physicians and respiratory therapists. In addition, clear evidence for the superiority of this novel mode has not yet been established. These factors have most likely hindered more widespread use of this mode in c…

Pulmonary and Respiratory Medicinemedicine.medical_specialtySLEEP QUALITYPressure controlled ventilationChronic hypercapniaHOME MECHANICAL VENTILATIONOBSTRUCTIVE PULMONARY-DISEASEAMYOTROPHIC-LATERAL-SCLEROSISlaw.inventionHypercapnia03 medical and health sciences0302 clinical medicineOBESITY-HYPOVENTILATION SYNDROMElawACUTE RESPIRATORY-FAILUREmedicineCOPDHumansLEAKS030212 general & internal medicineIntensive care medicineRANDOMIZED CROSSOVER TRIALClinical Trials as TopicHybrid ventilationNoninvasive Ventilationbusiness.industryTerm (time)Clinical PracticeSUPPORT NONINVASIVE VENTILATION030228 respiratory systemEvaluation Studies as TopicVentilation (architecture)Noninvasive ventilationbusinessRespiratory InsufficiencyConventional ventilationHumanThe European respiratory journal
researchProduct

Novel therapeutical approaches to managing atherosclerotic risk

2021

Atherosclerosis is a multifactorial vascular disease that leads to inflammation and stiffening of the arteries and decreases their elasticity due to the accumulation of calcium, small dense Low Density Lipoproteins (sdLDL), inflammatory cells, and fibrotic material. A review of studies pertaining to cardiometabolic risk factors, lipids alterations, hypolipidemic agents, nutraceuticals, hypoglycaemic drugs, atherosclerosis, endothelial dysfunction, and inflammation was performed. There are several therapeutic strategies including Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) inhibitors, inclisiran, bempedoic acid, Glucagon-Like Peptide-1 Receptor agonists (GLP-1 RAs), and nutraceuticals t…

QH301-705.5InflammationReview030204 cardiovascular system & hematologyPharmacologyCatalysisInorganic Chemistry03 medical and health sciences0302 clinical medicineLipid oxidationmedicineAnimalsHumans030212 general & internal medicineMolecular Targeted TherapyPhysical and Theoretical ChemistryEndothelial dysfunctionBiology (General)Molecular BiologyQD1-999SpectroscopyInnovative therapiesMolecular signalingVascular diseasebusiness.industryPCSK9Organic ChemistryGeneral MedicineProprotein convertasemedicine.diseaseAtherosclerosisComputer Science ApplicationsManagementChemistryInflammationsAtheromaOxidative stressHypolipidemic Agentslipids (amino acids peptides and proteins)Nutraceuticalsmedicine.symptombusiness
researchProduct